The global hospital-acquired infection diagnostics market was valued at $3.4 billion in 2020, and is projected to reach $7.0 billion by 2030, growing at a CAGR of 7.6% from 2021 to 2030.
https://www.alliedmarketresearch.com/request-sample/4447
The surge in number of hospitals, increased awareness regarding hospital acquired infections, and rise in global geriatric population along with upsurge in infectious virus during the pandemic fuel the growth of the global hospital acquired infection diagnostics market during the forecast period.
The major factors that drive global hospital-acquired infection diagnostics market share are the rise in geriatric population, the development of technologically improved diagnostic technologies, and the need for HAI diagnostics in middle- and low-income nations. A rise in knowledge about hospital-acquired infections, a boom in R&D spending, enhanced healthcare infrastructure, technological improvements, and greater government actions around the world, all contribute to the expansion.
The hospital-acquired infection diagnostics market size is segmented on the basis of product, test type, application, infection type, end user, and region. By product, the industry is split into instrument &reagents and consumables. The reagents segment dominated the market. Growth of the segment is attributed to low awareness and high prevalence of hospital acquired infections in low and middle income countries. By test type, the market is classified into molecular diagnostics, urinalysis, and immunoassay. The molecular diagnosis segment dominated the market. The growth of the segment can be attributed to surge in infectious diseases, cancer, and sudden outbreak of pandemic. By application type, the market is bifurcated into disease testing and drug resistance testing. The drug-resistance testing segment dominated during the hospital-acquired infection diagnostics market forecast.
Furthermore, by infection type, it is classified into hospital acquired pneumonia, bloodstream infections, surgical site infections, gastrointestinal infections, urinary tract infections (UTI), and others. The respiratory infections segment dominated the market which is attributed to high prevalence of pneumonia in hospitalized patients. Depending on end users, the market is fragmented into hospitals, clinics, ambulatory surgery centres (ASC), and others. The hospital segment accounted for the largest segment in the market which was attributed to the outburst of pandemic and sudden surge of patients.
Hospital-Acquired Infection Diagnostics Market Report Highlights:
By Product:
Instrument
Reagents and Consumables
By Test Type:
Molecular Diagnostics
Immunoassay
Others
By Application:
Disease Testing
Drug-Resistance Testing
By Infection Type:
Hospital Acquired Pneumonia
Bloodstream Infections
Surgical Site Infections
Gastrointestinal Infections
Urinary Tract Infections (UTI)
Others
By End User:
Hospital
Standalone Laboratories
Others
By Region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
Asia-Pacific (Japan, China, Australia, India, South Korea, Rest of LAMEA)
LAMEA (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
https://www.alliedmarketresearch.com/purchase-enquiry/4447
:
Major key players that operate in the global hospital acquired infection diagnostics market are Abott, Bayer, Becton Dickinson & Company, Danaher Corporation, Ecolab, Hologic, Johnson & Johnson, Merck Kgaa, Pfizer and Steris PLC.
Key Benefits For Stakeholders:
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the hospital-acquired infection diagnostics market analysis from 2020 to 2030 to identify the prevailing hospital-acquired infection diagnostics market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the hospital-acquired infection diagnostics market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
David Correa
Allied Market Research
+1 800-792-5285
email us here
Visit us on social media:
Facebook
X
Legal Disclaimer:
EIN Presswire provides this news content “as is” without warranty of any kind. We do not accept any responsibility or liability
for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this
article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
